We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$586B
AUM Growth
-$76.8B
Cap. Flow
-$24.4B
Cap. Flow %
-4.16%
Top 10 Hldgs %
27.57%
Holding
13,842
New
1,775
Increased
5,712
Reduced
4,842
Closed
1,482

Sector Composition

Rank Sector Weight
1 Technology 1.55%
2 Consumer Discretionary 0.95%
3 Financials 0.77%
4 Healthcare 0.67%
5 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGI icon
12201
PUT
Commercial Vehicle Group
CVGI
$126M
$12K ﹤0.01%
+10,400
New +$20.1K
BCAB icon
12202
BioAtla
BCAB
$5.43M
$11.7K ﹤0.01%
674
-3,611
-84% -$77.2K
NPWR.WS icon
12203
NET Power Inc Warrants
NPWR.WS
$27M
$11.5K ﹤0.01%
+37,685
New +$81.5K
CCO icon
12204
PUT
Clear Channel Outdoor Holdings
CCO
$1.21B
$11.3K ﹤0.01%
+10,200
New +$13.5K
VEEE icon
12205
Twin Vee PowerCats
VEEE
$5.79M
$11.3K ﹤0.01%
+92
New +$14.1K
CBAT icon
12206
PUT
CBAK Energy Technology Ltd
CBAT
$84.2M
$11.3K ﹤0.01%
14,100
PTN
12207
Palatin Technologies
PTN
$18.5M
$11.1K ﹤0.01%
380
-652
-63% -$30.4K
ONCY
12208
Oncolytics Biotech
ONCY
$110M
$11K ﹤0.01%
+19,994
New +$14.6K
ENLV icon
12209
Enlivex Ltd
ENLV
$26.6M
$10.5K ﹤0.01%
722
-22
-3% -$366
TSBX
12210
DELISTED
Turnstone Biologics
TSBX
$10.4K ﹤0.01%
25,305
-42,019
-62% -$17.9K
TPST icon
12211
CALL
Tempest Therapeutics
TPST
$18.4M
$10.4K ﹤0.01%
+1,077
New +$12.2K
EAF icon
12212
PUT
GrafTech
EAF
$175M
$10.2K ﹤0.01%
1,170
-440
-27% -$5.72K
NXPL icon
12213
NextPlat
NXPL
$24.7M
$10.1K ﹤0.01%
+1,219
New +$12.7K
CERO
12214
DELISTED
CERo Therapeutics
CERO
$9.74K ﹤0.01%
+667
New +$26.4K
CLSD
12215
PUT
DELISTED
Clearside Biomedical
CLSD
$9.66K ﹤0.01%
+700
New +$10.1K
MYND
12216
Mynd.ai
MYND
$19.9M
$9.63K ﹤0.01%
11,329
-10,075
-47% -$12.5K
DMYY.WS
12217
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
$9.54K ﹤0.01%
+10,044
New +$4.4K
VFF icon
12218
Village Farms International
VFF
$352M
$9.47K ﹤0.01%
15,660
-110,964
-88% -$81K
ASBP
12219
Aspire Biopharma
ASBP
$11.6M
$9.34K ﹤0.01%
+13
New +$89.9K
WBX
12220
Wallbox
WBX
$72.5M
$9.01K ﹤0.01%
+1,375
New +$12.5K
VFF icon
12221
CALL
Village Farms International
VFF
$352M
$9K ﹤0.01%
+15,000
New +$10.9K
CMBM
12222
DELISTED
Cambium Networks
CMBM
$8.88K ﹤0.01%
+12,590
New +$12.3K
GAME icon
12223
GameSquare
GAME
$47.4M
$8.76K ﹤0.01%
+1,842
New +$12K
BOLT icon
12224
Bolt Biotherapeutics
BOLT
$7.42M
$8.69K ﹤0.01%
+1,087
New +$10.4K
VXRT
12225
PUT
DELISTED
Vaxart
VXRT
$8.69K ﹤0.01%
21,200
-53,200
-72% -$34.1K

Similar funds

Jeff Yass's Q1 2025 Portfolio in Review

As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.

  • Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
  • Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
  • Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
  • Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
  • Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
  • Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.